STOCK TITAN

Hims & Hers (NYSE: HIMS) director acquires 4,613 shares via RSU grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health director David B. Wells exercised stock units granted as board compensation and received additional common shares. On June 11, 2026 he converted 3,656 Restricted Stock Units into Class A Common Stock, and on June 15, 2026 he converted another 957 units, for a total of 4,613 shares. These RSUs were issued under the company’s Director Compensation Policy in lieu of $22,000 of cash fees, based on a grant price of $22.98 per unit. After these routine compensation-related transactions, Wells directly holds 229,030 shares of Class A Common Stock.

Positive

  • None.

Negative

  • None.
Insider WELLS DAVID B
Role null
Type Security Shares Price Value
Exercise Restricted Stock Unit 957 $0.00 --
Exercise Class A Common Stock 957 $0.00 --
Exercise Restricted Stock Unit 3,656 $0.00 --
Exercise Class A Common Stock 3,656 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct, null); Class A Common Stock — 229,030 shares (Direct, null)
Footnotes (1)
  1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
RSUs exercised total 4,613 shares RSU conversions on June 11 and June 15, 2026
RSUs exercised June 11, 2026 3,656 shares Restricted Stock Units converted into Class A Common Stock
RSUs exercised June 15, 2026 957 shares Restricted Stock Units converted into Class A Common Stock
Post-transaction holdings 229,030 shares Class A Common Stock directly held after transactions
Foregone cash fees $22,000 Director retainer and committee fees replaced with RSUs for Q1 2026
RSU grant price $22.98 per unit Used to convert $22,000 of fees into RSUs
Restricted Stock Units financial
"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Director Compensation Policy financial
"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer"
contingent right financial
"Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WELLS DAVID B

(Last)(First)(Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CALIFORNIA 94123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/11/2026M3,656A(1)228,073D
Class A Common Stock06/15/2026M957A(2)229,030D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/11/2026M3,656 (1) (1)Class A Common Stock3,656$00D
Restricted Stock Unit(3)06/15/2026M95706/15/2026 (2)Class A Common Stock957$00D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.
2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.
3. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for David B Wells06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did HIMS director David B. Wells report?

David B. Wells reported exercising Restricted Stock Units and receiving Class A Common Stock. On June 11 and June 15, 2026, he converted 4,613 RSUs into shares as part of routine director compensation, with no open-market stock purchases or sales disclosed.

How many Hims & Hers (HIMS) shares did David B. Wells acquire?

David B. Wells acquired 4,613 shares of Class A Common Stock through RSU conversions. These came from two grants of 3,656 and 957 Restricted Stock Units, which each convert into one share, reflecting equity compensation rather than market trading activity.

What is David B. Wells’ HIMS shareholding after these transactions?

After the reported transactions, David B. Wells directly holds 229,030 shares of Hims & Hers Class A Common Stock. This total reflects the added shares from RSU conversions and provides context for his ongoing equity stake as a company director.

How were the HIMS RSUs for David B. Wells calculated and granted?

The RSUs were granted under the company’s Director Compensation Policy, replacing cash retainers. The number of units was calculated by dividing foregone cash fees of $22,000 by a grant price of $22.98 per unit, resulting in equity-based compensation instead of cash.

When do David B. Wells’ HIMS Restricted Stock Units vest?

The filing describes RSUs that vest upon continued service. One grant vests on the earlier of the 2026 annual stockholders’ meeting or June 15, 2026, while another is scheduled to vest in full on the company’s next quarterly vesting date.